Delivery Order SPE2DB24D3013-SPE2DB25FFPYS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for NURTEC ODT 75 mg tablets in quantities of eight units, valued at $6,465.10. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of August 20, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $33,700.47 for NURTEC ODT 75 mg tablets (8-count units) on August 25, 2025, with completion anticipated by August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) valued at $1,827.24. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a $34,561.46 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $5,362.99. This firm fixed price delivery order, which is due for completion by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award was made...
- The Defense Logistics Agency awarded a $37,622.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine in adults and represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $54,649.34 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine,...
- The Defense Logistics Agency awarded a delivery order valued at $9,267.76 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). The award was made on a competitive basis with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 21, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPYSDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,431.99 on August 28, 2025, for NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to military and veteran healthcare systems through this prime vehicle. NURTEC ODT is a migraine treatment medication, consistent with the company's portfolio of neurological and specialty pharmaceuticals supporting Defense Health Agency and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/28/25 |